WuXi PharmaTech Receives 2013 Lilly Global Supplier Award
May 01, 2014
May 1, 2014
WuXi PharmaTech (Cayman) Inc.
(NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in
the United States
, today announced that the company has received the 2013 Lilly Global Supplier Award. This is the third time that WuXi has been honored with this award from
Eli Lilly and Company
. This award was established to recognize the exceptional efforts of Lilly's suppliers in providing the company with a competitive advantage. The honor recognizes WuXi AppTec's contributions to Lilly's drug development programs.
"We are honored to receive this award from Lilly in recognition of the skill and hard work of WuXi scientists," said Dr.
, Chairman and Chief Executive Officer. "This award reflects our commitment to provide high-quality services to Lilly and to all of our 1,700 global customers. We continue our mission to build a broad, integrated platform of R&D services that enables anyone and any company to discover, develop and commercialize healthcare products to benefit patients globally."
(NYSE: WX) is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in
the United States
. As a research-driven and customer-focused company,
provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process.
services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of
are known as WuXi AppTec.
For more information, please contact:
Director of Investor Relations
+1 (201) 585-2048
Associate Director of Corporate Communications